Raludotatug deruxtecan (DS-6000) is an experimental anti-cancer treatment developed by Daiichi Sankyo and Merck.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.